在采用细胞疗法中增强免疫细胞贩运的最佳化学因受体

DoYeon Han1,2, Byung-Kwan Jeong1, Jong Moo Hong1,2

  • 1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro, 43-Gil, Songpa-Gu, Seoul, 05505, Korea.

Immunologic research
|January 15, 2025
PubMed
概括

这项研究确定了五种化学因受体,以改善固体瘤的采用细胞疗法 (ACT). 针对这些受体,如CXCR5,可以增强免疫细胞向瘤的迁移,从而提高癌症治疗的有效性.